Medtronic (NYSE:MDT) CEO Omar Ishrak put the kaibosh on a spinout for the company’s spine business, telling Reuters that all of the company’s parts add up to a greater whole, with one notable exception – its Physio-Control external defibrillator unit.
“[O]ur assessment is that the different pieces of Medtronic [together] actually add value,” Ishrak told the news service, but added that the company is still considering a sale of Physio-Control.